BiCMOS Implementation of Cell Signaling for Cell Survival/Death

: A well-structured and controlled design methodology, along with a supporting hierarchical design system, has been developed to optimally support the development effort on several programs requiring gate array and semi custom Very Large Scale Integration (VLSI) design. In this paper, we will present an application of VLSI in System Biology. This work examines signaling networks that control the survival decision treated with combinations of three primary signals the pro death cytokine, tumor necrosis factor-α (TNF), and the pro survival growth factors, epidermal growth factor (EGF) and insulin. We have made model by taking three inputs, than made the truth table, Boolean equation and than implement the equation using BiCMOS logic circuit.

[1]  J. Lotem,et al.  Cytokines as suppressors of apoptosis , 1999, Apoptosis.

[2]  Masato Kasuga,et al.  Role of binding proteins to IRS-1 in insulin signalling , 1998, Molecular and Cellular Biochemistry.

[3]  Weixin Zhou,et al.  STAT3 in EGF Receptor-Mediated Fibroblast and Human Prostate Cancer Cell Migration, Invasion and Apoptosis. , 2006 .

[4]  N. Normanno,et al.  Epidermal growth factor receptor (EGFR) signaling in cancer. , 2006, Gene.

[5]  M. Weber,et al.  RAS and RAF-1 form a signalling complex with MEK-1 but not MEK-2 , 1994, Molecular and cellular biology.

[6]  J Downward,et al.  Interaction of Ras and Raf in intact mammalian cells upon extracellular stimulation. , 1994, The Journal of biological chemistry.

[7]  S. Bhattacharya,et al.  Signaling through the JAK/STAT pathway, recent advances and future challenges. , 2002, Gene.

[8]  Eileen D. Adamson,et al.  Epidermal growth factor receptors , 1981, Molecular and Cellular Biochemistry.

[9]  Gaochao Zhou,et al.  Components of a New Human Protein Kinase Signal Transduction Pathway (*) , 1995, The Journal of Biological Chemistry.

[10]  Abbreviations , 1971 .

[11]  T. Libermann,et al.  Expression of epidermal growth factor receptors in human brain tumors. , 1984, Cancer research.

[12]  Dario R. Alessi,et al.  The insulin signalling pathway , 2002, Current Biology.

[13]  M. White,et al.  The insulin signalling system and the IRS proteins , 1997, Diabetologia.

[14]  D. Lauffenburger,et al.  A Systems Model of Signaling Identifies a Molecular Basis Set for Cytokine-Induced Apoptosis , 2005, Science.

[15]  K. Vermeulen,et al.  Apoptosis: mechanisms and relevance in cancer , 2005, Annals of Hematology.

[16]  N. K. Sah,et al.  Mitochondria can power cells to life and death , 2000 .

[17]  M. White.  Insulin Signaling in Health and Disease , 2003, Science.

[18]  M. Cobb,et al.  Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. , 2001, Endocrine reviews.

[19]  T. Fan,et al.  Apoptosis-inducing factor and apoptosis. , 2003, Sheng wu hua xue yu sheng wu wu li xue bao Acta biochimica et biophysica Sinica.

[20]  P. Scheurich,et al.  Identification of a 60-kD tumor necrosis factor (TNF) receptor as the major signal transducing component in TNF responses , 1990, The Journal of experimental medicine.

[21]  P. Cohen,et al.  Conversion of SB 203580-insensitive MAP kinase family members to drug-sensitive forms by a single amino-acid substitution. , 1998, Chemistry & biology.

[22]  Jongkyeong Chung,et al.  Akt: versatile mediator of cell survival and beyond. , 2002, Journal of biochemistry and molecular biology.

[23]  H. Schoenfeld,et al.  Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[24]  A. Bridges,et al.  A synthetic inhibitor of the mitogen-activated protein kinase cascade. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[25]  Angelo Nicolin,et al.  mTOR: a protein kinase switching between life and death. , 2004, Pharmacological research.